Antithrombin-III for New Coronavirus Infection (COVID-19) Under Conditions of Extracorporeal Membrane Oxygenation (Clinical Observation)

Antithrombin-III for New Coronavirus Infection (COVID-19) Under Conditions of Extracorporeal Membrane Oxygenation (Clinical Observation)

COVID-19 is a disease that, in addition to respiratory failure, leads to thrombosis and bleeding due to coagulation disorders. Extracorporeal membrane oxygenation (ECMO), required in cases of a deterioration of gas exchange function of the lungs, contributes to changes in blood coagulation indicator...

Full description

Saved in:
Bibliographic Details
Main Authors: S. V. Zhuravel, V. V. Vladimirov, P. V. Gavrilov, I. V. Ivanov, S. S. Petrikov, K. A. Popugayev, A. M. Talyzin
Format: Article
Language:Russian
Published: Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department 2022-01-01
Series:Неотложная медицинская помощь
Subjects:
covid-19
sars-cov-2
ecmo
thrombosis
bleeding
antithrombin
heparin
anticoagulant therapy
Online Access:https://www.jnmp.ru/jour/article/view/1261
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items